Pediatr. praxi. 2010;11(3):162-164

Probiotics in pediatric practice

MUDr.Jiří Bronský, Ph.D.
Oddělení dětské gastroenterologie, Pediatrická klinika UK 2. LF a FN Motol, Praha

Probiotics are live microorganisms which – applied in appropriate amount – positively influence health status of the recipient. Main

mechanism of their effect is the influence on intestinal mucosal barrier and host immune response. It is necessary to consider effect

of specific probiotic strain in a specific clinical situation by Evidence-based medicine. From this point of view, positive effect has been

shown in Lactobacillus GG, Lactobacillus reuteri, Enterococcus faecium or Saccharomyces boulardii. Positive effect of probiotics is proven in

patients with necrotising enterocolitis, infectious and post-antibiotic diarrhoea, in the prevention of atopic eczema and in maintainance

of remission in idiopathic proctocolitis and chronic pauchitis.

Keywords: probiotics, bifidobacteria, lactobacilli, clostridia, randomised controlled trials

Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bronský J. Probiotics in pediatric practice. Pediatr. praxi. 2010;11(3):162-164.
Download citation

References

  1. Saavedra JM. Use of probiotics in pediatrics: Rationale, mechanisms of action, and practical aspects. Nutrition in Clinical Practice 2007; 22: 351-365. Go to original source... Go to PubMed...
  2. Favier CF, Vaughan EE, de Vos WM, et al. Molecular monitoring of succession of bacterial communities in human neonates. Applied and Environmental Microbiology 2002; 68: 219-226. Go to original source... Go to PubMed...
  3. Olivares M, Díaz-Ropero MA, Gómez N, et al. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol 2006; 107(2): 104-111. Go to original source... Go to PubMed...
  4. Ruemmele FM, Bier D, Marteau P, et al. Clinical Evidence for Immunomodulatory Effects of Probiotic Bacteria. J Ped Gastroenterol Nutr 2009; 48: 126-141. Go to original source... Go to PubMed...
  5. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birth-weight: a systematic review of randomised controlled trials. Lancet 2007; 369: 1614-1620. Go to original source... Go to PubMed...
  6. Guarino A, et al. ESPGHAN/ESPID Evidence-Based Guidelines for the management of Acute Gastroenteritis in Children in Europe. J Pediatr Gastroenterol Nutr 2008; 46(5): 619-621. Go to original source... Go to PubMed...
  7. Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2005; 22(5): 365-372. Go to original source... Go to PubMed...
  8. Szajewska H, Skórka A, Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25(3): 257-264. Go to original source... Go to PubMed...
  9. Kirjavainen PV, Apostolou E, Arvola T, et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunology and Medical Microbiology 2001; 32: 1-7. Go to original source... Go to PubMed...
  10. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134. Go to original source... Go to PubMed...
  11. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-114. Go to original source... Go to PubMed...
  12. Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottlefed infants. Microbiol Immunol 1984; 28: 975-986. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.